Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research.
about
Human malarial disease: a consequence of inflammatory cytokine releaseCytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of ageCerebral malaria: gamma-interferon reduxPhase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsA role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.CD8(+) T cell activation by murine erythroblasts infected with malaria parasites.Nyctanthes arbor-tristis positively affects immunopathology of malaria-infected mice prolonging its survival.Plasmodium-induced inflammation by uric acidMeta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.Cross-species malaria immunity induced by chemically attenuated parasites.Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulationType I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity.Dual effect of Plasmodium-infected erythrocytes on dendritic cell maturation.Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses.The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs.Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.Helminth parasites alter protection against Plasmodium infection.New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses?Plasmodium immunomics.Co-infection of helminths and malaria: modulation of the immune responses to malaria.Resistance to malaria by enhanced phagocytosis of erythrocytes in LMP7-deficient mice.Endothelial cells potentiate interferon-γ production in a novel tripartite culture model of human cerebral malaria.Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection.PD-1 deficiency enhances humoral immunity of malaria infection treatment vaccine.A re-evaluation of the role of B cells in protective immunity to Chlamydia infectionVirus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease.Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA miceExpression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection.Plasmodium yoelii blood-stage primes macrophage-mediated innate immune response through modulation of toll-like receptor signalling.IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.A Plasmodium-encoded cytokine suppresses T-cell immunity during malariaMacrophage Colony Stimulating Factor Derived from CD4+ T Cells Contributes to Control of a Blood-Borne InfectionMalaria vaccines in development.Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria.ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in BrazilAssessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection
P2860
Q21034098-DDB02072-4315-448C-B65A-8495E878A2CFQ21034151-D40C753D-7BA0-4166-903A-3A1D4E42CE4AQ26824074-34929764-FCA4-4FEF-A689-C72A8DE603E7Q28731894-7F0BF7F2-2055-4DE9-A1A6-01AD5985E5E3Q30479825-0B1B0EC6-E282-4F85-9E9A-9A40A32E2C07Q30538105-7D51614D-5E39-4D8A-A292-96FEAD993B83Q30620306-DD701022-E333-4604-B56C-650B49B36223Q33325912-86C11EF5-815F-4B0F-BCCA-031B7B79BBF7Q33400526-F0F24AAD-FCCF-49AB-A5AF-2F470B7DD95EQ33570804-DA2BBECF-996D-4AAE-9E7F-4BDD36698C3EQ33618034-B4AF075C-9706-43D4-A806-72C49E666BA2Q33685904-234035C6-97A2-4013-9A90-56C0BC0AB541Q33741807-59E23677-6F61-4D7C-B1BB-FA4348466203Q33776347-E28A452C-6B4A-42B1-A8F2-CECB831FA763Q33936854-423D067B-7BCC-4643-9B3E-BE5CBCD27D74Q34075263-01A11786-96DA-42B6-A0E9-BED0C769939EQ34142179-077AAEE9-CA17-4761-8E13-2D098F9BB788Q34161839-D741B688-C223-4323-A4D4-9A53990180E4Q34222238-57C224A5-EBD2-4F3D-BC75-C1814623A3ACQ34290768-365690BE-A6CA-4EE0-8C7D-26212173BB84Q34290893-CAD30971-8C26-4B27-BE2C-550568174F76Q34419934-2445996A-D989-4F00-8900-1E9F38F60E7AQ34565140-A43C1635-56CB-401F-B935-5BEFA1F2D1A3Q34635361-D2416A5A-5D27-418D-A73D-F2E24117C12FQ34854215-9B3FFB83-8C62-41F5-9638-5098E6D9113EQ35215354-3FD6FE2C-5CBC-47A3-884B-8E70CF6DA830Q35439757-24EB7EBF-8B02-45F4-9C9C-F769BD61EC54Q35471373-B127B3D3-B631-4097-BDF6-84D2D876F947Q35557138-3C5D1369-7B88-4EE9-804A-7FF14B6B6EDCQ35839239-2BA2B4E0-C63C-48CB-96D2-861EC88CC22BQ35907413-0724653D-AC25-43AB-870A-B485FF36A669Q35927802-5979E1F1-6E97-4A06-94F9-C39285728CEEQ36086895-041D9469-04B0-44E3-B8A1-E35C97F320A0Q36140303-697C2DCB-8CF6-4A0B-B65C-5377801EFD69Q36214299-404C6E52-B85D-4515-9680-91E147FAD2A8Q36219634-D2116A45-2397-43BD-AE05-1AF0CB0A85DFQ36455241-49239075-67CE-4A60-9911-89D941B42EB5Q36460499-D930CA81-284A-4CD8-AEF4-A885BAE61D4BQ36510364-23B40C23-1AA1-41F0-83C2-880777276923Q36903515-27E39A11-2902-4C7D-A8BE-5BE888CAF303
P2860
Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Development and regulation of ...... ications for vaccine research.
@ast
Development and regulation of ...... ications for vaccine research.
@en
type
label
Development and regulation of ...... ications for vaccine research.
@ast
Development and regulation of ...... ications for vaccine research.
@en
prefLabel
Development and regulation of ...... ications for vaccine research.
@ast
Development and regulation of ...... ications for vaccine research.
@en
P50
P1476
Development and regulation of ...... ications for vaccine research.
@en
P2093
P356
10.1146/ANNUREV.IMMUNOL.23.021704.115638
P577
2005-01-01T00:00:00Z